Genmab has announced that its phase 3 EPCORE FL-1 trial met both primary endpoints in patients with relapsed or refractory ...

Genmab ( ($GMAB) ) just unveiled an update. On August 13, 2025, Genmab A/S announced updates to its Articles of Association, including ...

The current $195 million investment is part of a commitment to invest more than $10 billion for innovation and manufacturing capacity enhancement.

AbbVie is investing $195m to strengthen domestic API production, with the expansion of its manufacturing plant in North ...

(Reuters) -European shares hit a near two-week high on Wednesday, underpinned by gains in heavyweight healthcare and ...

Nutritionals group Glanbia was the big story of the day on the Irish market as it climbed almost 16% after raising earnings ...

European stock markets reached a near two-week high, driven by substantial gains in healthcare and technology sectors.